Literature DB >> 12915249

Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study.

Robert Y Moore1, Alan L Whone, Stephen McGowan, David J Brooks.   

Abstract

18F-DOPA positron emission tomography (PET) has been used for two decades to study the organization and pathology of the striatal dopamine system in the human brain, particularly in Parkinson's disease. High resolution 3D PET allows a more detailed analysis than previously available and was employed in this study to determine the regional uptake of 18F-DOPA in control brain. Eleven healthy volunteers underwent 18F-DOPA PET with a region of interest (ROI) study performed using individual volumetric MRI's coregistered to the PET ADD image. A Patlak linear graphical analysis was undertaken to obtain influx constant (Ki) values. The highest Ki values were from neostriatal areas, with a rostrocaudal gradient of increasing Ki values from head of caudate nucleus to rostral putamen to caudal putamen. However, Ki values for transaxial slices from dorsal to ventral through the caudate and putamen were uniform. Ventral striatum Ki was 81% with red nucleus and globus pallidus Ki values of approximately 40% of neostriatum. In limbic areas, highest values were obtained from amygdala (35% neostriatal Ki). Neocortical Ki values varied from 22% in temporal pole to 6% in occipital cortex of neostriatal values. Hypothalamic Ki was high (45%) in comparison to thalamus (17%) and retina (17%). 18F-DOPA is taken up by serotonin (raphe, 51%), and noradrenaline (locus coeruleus, 37%) as well as dopamine neurons. These data indicate that 18F-DOPA PET can be used with detailed, anatomically based ROIs as a tool for in vivo analysis of regional changes in monoamine neuron systems throughout the brain in Parkinson's disease and other disorders.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915249     DOI: 10.1016/s0006-8993(03)02721-5

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  20 in total

Review 1.  Neuroimaging in Parkinson's disease.

Authors:  A Jon Stoessl
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals.

Authors:  Paul Allen; Judy Luigjes; Oliver D Howes; Alice Egerton; Kazuyuki Hirao; Isabel Valli; Joseph Kambeitz; Paolo Fusar-Poli; Matthew Broome; Philip McGuire
Journal:  Schizophr Bull       Date:  2012-01-30       Impact factor: 9.306

3.  A dual-tracer study of extrastriatal 6-[18F]fluoro-m-tyrosine and 6-[18F]-fluoro-L-dopa uptake in Parkinson's disease.

Authors:  Clarence T Li; Matthew Palotti; James E Holden; Jen Oh; Ozioma Okonkwo; Bradley T Christian; Barbara B Bendlin; Laura Buyan-Dent; Sandra J Harding; Charles K Stone; Onofre T DeJesus; Robert J Nickles; Catherine L Gallagher
Journal:  Synapse       Date:  2014-04-22       Impact factor: 2.562

4.  Anterior cingulate dopamine turnover and behavior change in Parkinson's disease.

Authors:  Catherine L Gallagher; Brian Bell; Matthew Palotti; Jen Oh; Bradley T Christian; Ozioma Okonkwo; Jitka Sojkova; Laura Buyan-Dent; Robert J Nickles; Sandra J Harding; Charles K Stone; Sterling C Johnson; James E Holden
Journal:  Brain Imaging Behav       Date:  2015-12       Impact factor: 3.978

5.  The neurobiology of glucocerebrosidase-associated parkinsonism: a positron emission tomography study of dopamine synthesis and regional cerebral blood flow.

Authors:  Ozlem Goker-Alpan; Joseph C Masdeu; Philip D Kohn; Angela Ianni; Grisel Lopez; Catherine Groden; Molly C Chapman; Brett Cropp; Daniel P Eisenberg; Emerson D Maniwang; Joie Davis; Edythe Wiggs; Ellen Sidransky; Karen F Berman
Journal:  Brain       Date:  2012-08       Impact factor: 13.501

Review 6.  The dopamine hypothesis of schizophrenia: version III--the final common pathway.

Authors:  Oliver D Howes; Shitij Kapur
Journal:  Schizophr Bull       Date:  2009-03-26       Impact factor: 9.306

Review 7.  Mechanisms underlying psychosis and antipsychotic treatment response in schizophrenia: insights from PET and SPECT imaging.

Authors:  O D Howes; A Egerton; V Allan; P McGuire; P Stokes; S Kapur
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

8.  Selective hyposmia and nigrostriatal dopaminergic denervation in Parkinson's disease.

Authors:  Nicolaas I Bohnen; Satyanarayana Gedela; Hiroto Kuwabara; Gregory M Constantine; Chester A Mathis; Stephanie A Studenski; Robert Y Moore
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

Review 9.  Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis.

Authors:  Oliver D Howes; Andrew J Montgomery; Marie-Claude Asselin; Robin M Murray; Paul M Grasby; Philip K McGuire
Journal:  Br J Psychiatry Suppl       Date:  2007-12

10.  The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function.

Authors:  Mitul A Mehta; Oliver D Howes; Alice Egerton; Arsime Demjaha; Philip McGuire
Journal:  Neuroimage       Date:  2009-12-23       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.